Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email


Check back regularly for news, coverage, and announcements about MAVA.


Chevy Chase-Based NEA Invests $10 Million in Apnex Medical

New Enterprise Associates (NEA), the Chevy Chase-based venture capital firm, said it has invested $10 million in Minnesota-based Apnex Medical, a developer of medical devices used to treat patients with sleep disordered breathing. The company will use the funds to support an ongoing clinical study evaluating the safety and effectiveness of its Hypoglossal Nerve Stimulation (HGNS) system in patients with obstructive sleep apnea (OSA). "It enables us to continue our randomized clinical trial of the HGNS System and build evidence to support its use in appropriate patients with OSA," said Robert Atkinson, the founder, president and CEO of Apnex Medical. During sleep, the implantable system detects a patient's breathing and delivers mild stimulation to the hypoglossal nerve, which controls the muscles that keep the airway open.

Read More